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ABSTRACT 
Objective: Diabetes mellitus is a chronic metabolic disease which affects our body's ability to use the energy found in food. Our study was planned 
to isolate chemical constituents from the leaves of Psidium guajava L. (Myrtaceae), to characterize their structures and to investigate their 
antidiabetic activity.  
Methods: The air-dried leaf powder was exhaustively extracted with methanol in a Soxhlet apparatus. The concentrated leaf extact was adsorbed 
on silica gel (60-120 mesh) for the preparation of a slurry. The dried slurry was chromatographed over silica gel column packed in petroleum ether. 
The column was eluted with petroleum ether, chloroform and methanol, successively, in order of increasing polarity to isolate the compounds. 
These natural constituents were tested for the antidiabetic activity in STZ-induced diabetic models. 
Results: Six new lanosterol-type triterpenoids characterized as lanost-7-en-3β-ol-26-oic acid (2), lanost-7-en-3β, 12β-diol-26-oic acid (3), lanost-7-
en-3β, 12β, 29-triol-26-oic acid (4), lanost-cis-1,7,23-trien-3β, 12β, 18, 22α-tetraol-26-oic acid (5), lanosteryl-3β-O-D-xylopyranosyl-2′-p-
benzaldehyde (7) and lanost-7-en-3β-ol-26-oic acid-3β-D-glucopyranoside (8) along with the known compounds arachidic acid (1) and β-sitosterol 
xylopyranoside (6) were isolated from the leaves. The compounds 2, 3, 4 and 8 exhibited significant antidiabetic activity against streptozotocin-
induced diabetic rats.  
Conclusion: The leaves of P. guajava possessed antidiabetic lanostene-type triterpenoids.  
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Diabetes mellitus (DM) is a chronic, lifelong disease which affects 
our body's ability to use the energy found in food. It is a group of 
metabolic diseases characterized by high blood sugar, frequent 
urination, excessive thirst and increased hunger. DM is due to either 
the pancreas is not producing sufficient insulin or the cells of the 
body not responding properly to the insulin produced. At present 
nearly 387 million people, equal to 8.3% of the adult population 
with equal rates of males and females, have diabetes worldwide, 
with type 2 diabetes suffering about 90% of the cases [1]. Presently, 
herbal medicines are mainly used to control the disease due to less side 
effects [2]. In recent years, herbal medicines have started to gain 
importance as a source of hypoglycemic agents. The plant products are 
rich in phenolic compounds, flavonoids, terpenoids, coumarins, and 
other constituents which show a reduction in blood glucose levels [3, 4].  
Psidium guajava L. (Myrtaceae), universally known as guava, is a 
native to Mexico and Peru and now cultivated in many countries as a 
shrub or small evergreen tree with many branches [5, 6]. Its fruits, 
known as the ‘poor man’s apple’ enrich the diets of millions of people 
in the tropics of the world [7]. A decoction of the leaves is used as a 
febrifuge, antispasmodic and to treat bronchitis, asthma, cough, 
pulmonary diseases and rheumatism. A leaf paste is applied as an 
antiseptic to cure wounds, ulcers and toothache [8-12]. The guava 
leaves have been reported to contain β-sitosterol, pentacyclic 
triterpenoids, quercetin, avicularin, its 3-L-4-pyranoside, resin, tannin, 
flavinone-2 2’-ene, prenol, dihydro-benzo-phenanthridine and a 
volatile oil rich in cineole, eugenol and cryptonine [13-15]. Guavas 
yield carotenoids and polyphenols, the major classes of antioxidant 
pigments giving them relatively high potential antioxidant value 
among plant foods [16]. The leaves showed antimicrobial, antioxidant, 
anticough, central nervous system, hypoglycaemic, antimutagenic and 
locomotor activities [5, 15]. During the course of our search for 
bioactive constituents from herbal drugs, we tested a crude extract of 
P. guajava for antidiabetic effect. Based upon the significant 
antidiabetic activity of the plant extract, we selected P. guajava for its 
phytochemical and antidiabetic studies.  
MATERIALS AND METHODS 
General procedures 
Melting points were determined by a thermoelectrically heated 
Perfit melting point apparatus without correction. UV spectra were 
measured with a Lambda Bio 20 spectrophotometer in methanol. 
Infrared (IR) spectra were recorded using KBr pellets with a Jasco 
FT-IR-5000 Spectrometer. The 1H (400 MHz) and 13C (100 MHz) NMR 
spectra were recorded on a Bruker ARX-Spectrometer by using CDCl3 
and DMSO-d6
Plant material 
 as solvents and TMS as an internal standard. Mass 
spectrometric detection was carried out on ESI-MS (Q-TOFESI), an 
electrospray-ionization (ESI) technique with positive ionization mode. 
Column chromatography was performed on silica gel 60–120 mesh and 
solvents taken were purchased from Merck Specialities Private Limited. 
Pre-coated aluminum TLC plates of silica gel 60 F254 were used to run 
and spots were visualized by exposure to iodine vapors, UV radiations 
and spraying with an anisaldehyde-sulfuric acid solution. 
P. guajava leaves were collected freshly from Faridabad, Haryana, 
India. The plant was identified by Prof. M. P. Sharma, Taxonomist, 
Department of Botany, Faculty of Science, Jamia Hamdard, New 
Delhi. A specimen voucher of the drug was deposited in the 
Phytochemistry Research Laboratory, Jamia Hamdard with a 
reference number PRL-JH/2008/05. 
Extraction and isolation 
The air-dried leaves (1.5 kg) were coarsely powdered and 
exhaustively extracted with methanol in a Soxhlet apparatus. The 
combined extracts were concentrated and dried on a steam bath 
under reduced pressure to get 225 g of a dark brown mass. It was 
dissolved in 250 ml methanol and adsorbed on silica gel (60-120 
mesh) for the preparation of a slurry. The slurry was dried in air and 
chromatographed over silica gel column packed in petroleum ether. 
The column was eluted with petroleum ether, petroleum ether–
chloroform (1:1, 1:3, v/v), chloroform and chloroform–methanol 
(97:3, 19:1 and 9:1, v/v) mixtures to isolate the compounds 1–8. 
International Journal of Pharmacy and Pharmaceutical Sciences 
ISSN- 0975-1491                  Vol 8, Issue 9, 2016 
Ali et al.  
Int J Pharm Pharm Sci, Vol 8, Issue 9, 14-18 
 
15 
Arachidic acid (1) 
Elution of the column with petroleum ether furnished colorless 
crystals of 1, recrystallized from acetone, 96 mg (0.064% yield); R f:  
0.52 (petroleum ether); m. p. and mixed m. p.: 62-63 °C; +ve FAB MS 
m/z (rel. int.): 313 [M+H]+(C20H41O2) (13.1).  
Psidiumlanostenoic acid (2) 
Elution of the column with petroleum ether-chloroform (1:1) 
mixture afforded colorless crystals of 2, recrystallized from acetone, 
886 mg (0.059% yield); R f :  0.46 (chloroform: methanol; 1:1); m. p.: 
176-178 °C; UV λmax (MeOH): 212, 276 nm (log ε 5.7, 3.2); IR νmax 
(KBr): 3415, 3312, 2931, 2850, 1688, 1640, 765 cm -1; 1H NMR 
(DMSO-d6): 5.03 (1H, brs, H-7), 3.75 (1H, dd, J = 5.3, 8.8 Hz,H-3α), 
1.25 (3H, brs, Me-29), 1.22 (3H, brs, Me-28), 1.18 (3H, brs, Me-30), 
1.15 (3H,d, J = 6.0 Hz, Me-21), 1.03 (3H, brs, Me-19), 0.92 (3H, d, J = 
6.3 Hz, Me-27), 0.85 (3H, brs, Me-18); 13C NMR (DMSO-d6) (table 
1);+ve FAB MS m/z (rel. int.): 459 [M+H]+(C30H51O3) (2.1).  
12β-Hydroxypsidiumlanostenoic acid (3) 
Elution of the column with petroleum ether-chloroform (1:3) 
mixture yielded colourless crystals of 3, recrystallized from acetone, 
732 mg (0.048% yield); R f :  0.48 (chloroform: methanol: 4:1); m. p.: 
218-220 °C; UV λmax (MeOH): 212, 277 nm (log ε 5.3, 2.8); IR νmax 
(KBr): 3419, 3315, 2932, 2855, 1694, 1640, 989 cm -1; 1H NMR 
(DMSO-d6): δ 5.13 (1H, m, H-7), 3.78 (1H, dd, J = 5.1, 9.5 Hz, H-3α), 
3.89 (1H, dd, J = 5.2, 9.3 Hz, H-12α), 1.22 (3H, brs, Me-28), 1.20 (3H, 
brs, Me-29), 1.16 (3H, d, J = 6.5 Hz, Me-21), 1.12 (3H, brs, Me-30), 
1.04 (3H, brs, Me-19), 0.98 (3H, d, J = 6.0 Hz, Me27), 0.83 (3H, brs, 
Me-18); 13C NMR (DMSO-d6) (table 1); FAB MS m/z (rel. int.): 475 
[M+H]+(C30H51O4) (2.3).  
Trihydroxypsidiumlanostenoic acid (4) 
Elution of the column with chloroform mixture afforded colorless 
crystals of 4, recrystallized from acetone, 564 mg (0.037% yield); Rf: 
0.64 (chloroform: methanol; 4:1); m. p.: 222-225 °C; UV λmax (MeOH): 
210, 281 nm (log ε 5.3, 1.1); IR νmax (KBr): 3423, 3381, 3275, 2925, 1690, 
1630, 956 cm -1; 1H NMR (DMSO-d6): δ 5.13 (1H, m, H-7), 3.75 (1H, dd, J 
= 5.2, 9.3 Hz, H-3α), 3.86 (1H, dd, J = 5.3, 9.1 Hz, H-12α), 3.40 (1H, brs, 
HOCH2-29a), 3.38 (1H, brs, HOCH2-29b), 1.15 (6H, brs, Me-28, Me-30), 
1.04 (3H, brs, Me-19), 0.99 (3H, d, J = 6.6 Hz, Me-21), 0.91 (3H, d, J = 6.1 
Hz, Me27), 0.87 (3H, brs, Me-18); 13C NMR (DMSO-d6) (table 1);+ve FAB 
MS m/z (rel. int.): 490 [M]+(C30H50O5) (2.6).  
Guavalanostenoic acid (5) 
Elution of the column with chloroform-methanol (97:3) mixture 
furnished colourless crystals of 5, recrystallized from acetone, 462 
mg (0.030 % yield); R f :  0.70 (chloroform: methanol; 1:1); m. p.: 188-
190 °C; UV λmax (MeOH): 211, 298 nm (log ε 5.1, 2.9); IR νmax (KBr): 
3410, 3367, 3281, 2934, 2850, 1692, 1603, 990 cm -1; 1H NMR 
(DMSO-d6): δ 6.51 (1H, dd, J = 8.4, 9.3 Hz, H-2), 6.79 (1H, d, J = 8.4 
Hz, H-1), 5.15 (1H,d, J = 9.0 Hz, H-7), 5.12 (1H, dd, J = 4.5, 8.1 Hz, H-
23), 5.01 (1H, dd, J = 8.1, 5.6 Hz, H-24), 4.49 (1H, d, J = 9.3 Hz, H-3α), 
4.30 (1H, dd, J = 4.5, 4.7 Hz, H-22β), 3.89 (1H, dd, J = 4.1,11.7 Hz, H-
12α), 3.42 (1H, brs, H2-18a), 3.39 (1H, brs, H2-18b), 1.23 (3H, brs, 
Me-29), 1.20 (3H, brs, Me-28), 1.15 (3H, brs, Me-30), 1.02 (3H, d, J = 
6.8 Hz, Me-21), 1.09 (3H, brs, Me-19), 0.99 (3H, d, J = 6.2 Hz, Me-27); 
13C NMR (DMSO-d6) (table 1);+ve FAB MS m/z (rel. int.): 503 
[M+H]+(C30H47O6) (2.2).  
β-Sitosterol xyloside (6) 
Elution of the column with chloroform-methanol (19:1) mixture 
gave colourless amorphous powder of 6, recrystallized from 
methanol, 286 mg (0.018% yield), R f: 0.32 (chloroform: methanol; 
4:1), m. p.: 270-272 °C; +ve FAB MS m/z (rel. int.): 547 [M+H]+ 
(C34H59O5
Elution of the column with chloroform-methanol (9:1) mixture 
furnished pale yellow crystals of 7, recrystallized from methanol, 
210 mg (0.014% yield); R
) (4.3). 
Psidium lanosteroside (7) 
f:  0.64 (toluene: ethyl acetate: formic acid; 
5:4:1); m. p.: 58-59 °C; UV λmax (MeOH): 212, 278 nm (log ε 4.9, 4.6); 
IR νmax (KBr): 3441, 3386, 2921, 2837, 1703, 1644, 950, 888 cm -1; 
1H NMR (DMSO-d6): δ 3.81 (1H, dd, J = 5.5, 9.0 Hz, H-3α), 1.27 (3H, 
brs, Me-29), 1.25 (3H, brs, Me-28), 1.20 (3H, d, J = 6.3 Hz, Me-21), 
1.16 (3H, brs, Me-30), 1.05 (3H, brs, Me-19), 0.98 (3H, d, J = 6.2 Hz, 
Me-27), 0.96 (3H, d, J = 6.1 Hz, Me-26), 0.89 (3H, brs, Me-18), 5.09 
(1H, d, J = 7.5 Hz, H-1'), 4.84 (1H, dd, J = 7.5, 6.3 Hz, H-2'), 4.71 (1H, 
m, H-3'), 3.96 (1H, m, H-4'), 3.71 (2H, d, J = 6.5 Hz, H2-5'), 7.23 (2H, 
m, H-2'', H-6''), 7.18 (2H, m, H-3'', H-5''), 10.6 (1H, brs, H-7''); 13C 
NMR (DMSO-d6) (table 1);+ve FAB MS m/z (rel. int.): 667 
[M+H]+(C42H67O6) (1.1), 429 (C30H53O) (15.3).  
Psidiumlanostenoic acid glucoside (8) 
Further elution of the column with chloroform-methanol (9:1) 
mixture gave colourless crystals of 8, recrystallized from methanol, 
586 mg (0.037% yield); R f :  0.86 (chloroform: methanol; 4:1); m. p.: 
179-180 °C; UV λmax (MeOH): 214, 248 nm (log ε 5.3, 4.6); IR νmax 
(KBr): 3410, 3389, 3250, 2924, 1692, 1650, 808 cm -1; 1H NMR 
(DMSO-d6): δ 5.28 (1H, d, J = 5.3 Hz, H-7), 3.72 (1H, dd, 5.2, 9.1 Hz, 
H-3α), 1.28 (3H, brs, Me-28), 1.19 (3H, brs, Me-29), 1.15 (3H, brs, 
Me-30), 1.06 (3H, brs, Me-19), 1.01 (3H, d, J = 6.3 Hz, Me-21), 0.95 
(3H, d, J = 6.2 Hz, Me27), 0.83 (3H, brs, Me-18), 5.08 (1H, d, J = 7.1 
Hz, H-1ʹ), 4.17 (1H, dd, J = 6.9, 7.1 Hz, H-2ʹ), 3.79 (1H, m, H-3ʹ), 3.51 
(1H, m, H-4ʹ), 4.63 (1H, m, H-5ʹ), 3.10 (1H, t, J = 6.9 Hz, H2-6'a), 3.07 
(1H, t, J = 6.9 Hz, H2-6'b); 13C NMR (DMSO-d6) (table 1);+ve FAB MS 
m/z (rel. int.): 621 [M+1]+(C36H61O8
Data were expressed as the mean ± SD For statistical analysis of 
the data, group means were compared by one-way analysis of 
variance (ANOVA) followed by Turkey post hoc test for multiple 
comparisons. P < 0.05 was considered to be statistically 
significant. 
) (3.1), 440 (7.3), 395 (26.5). 
Antidiabetic activity 
Antidiabetic activity of the compounds was performed by 
streptozotocin (STZ, Sigma chemicals, Mumbai)-induced diabetic 
model [30]. Male Albino Wistar rats (150-200 g) were used for this 
study. They were housed in macrolon cages under standard 
laboratory conditions (12 h light/12 h darkness, 21±2 °C). The 
animals were given standard pellets diet (Lipton rat feed, Ltd., Pune) 
and water ad libitum throughout the experimental period. The 
experimental study was approved by the Institutional Animal Ethical 
Committee of Jamia Hamdard, New Delhi. The animals were fasted 
for 16 h prior to the induction of diabetes. STZ freshly prepared in 
citrate buffer (0.1 M, pH 4.5) was administered intraperitoneal (i. p.) 
at a single dose of 60 mg/kg. Development of diabetes was 
confirmed by polydipsia, polyuria and by measuring blood glucose 
concentrations 72 h after injection of STZ. Rats with blood glucose 
level of 250 mg/dl or higher were considered to be diabetic. The rats 
were randomized into six groups comprising of six animals in each 
groups as given below. Tested compounds 2, 3, 4 and 8 (50 mg/kg) 
were administered orally in aqueous solution (3 % v/v tween 80 in 
water) once per day. 
Group I: control rats, received tween 80 (3 % v/v in water, 4 
ml/kg/day, p. o.) 3 d after citrate buffer (pH-4.5, 1 ml/kg, i. p.) 
treatment and continued for 7 d. 
Group II: diabetic control rats, received STZ in a single dose (60 
mg/kg, i. p.). 
Group III: Compound 2 treated diabetic rats, received compound 2 
(50 mg/kg/day, p. o.) 3 d after STZ treatment and continued for 7 d. 
Group IV: Compound 3 treated diabetic rats, received compound 3 
(50 mg/kg/day, p. o.) 3 d after STZ treatment and continued for 7 d. 
Group V: Compound 4 treated diabetic rats, received compound 4 
(50 mg/kg/day, p. o.) 3 d after STZ treatment and continued for 7 d. 
Group VI: Compound 8 treated diabetic rats, received compound 8 
(50 mg/kg/day, p. o.) 3 d after STZ treatment and continued for 7 d. 
Blood glucose was estimated by One Touch Glucometer (Accu-Check 
Roche, Germany). 
Statistical analysis 
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C NMR values of compounds 2-5, 7 and 8 isolated from Psidium guajava leaves 
 13C NMR values 
2 3 4 5 7 8 
1 36.36 36.37 36.33 130.17 35.12 36.33 
2 27.01 23.86 25.75 138.26 26.54 25.75 
3 79.87 80.30 78.54 83.61 77.85 78.54 
4 39.23 39.49 39.50 38.52 39.78 39.50 
5 46.06 41.73 42.50 46.86 56.54 42.50 
6 18.04 17.21 17.44 18.08 19.49 17.44 
7 124.62 124.56 124.53 121.48 28.88 124.53 
8 138.21 138.27 138.28 143.92 44.45 138.28 
9 54.83 54.82 52.38 54.78 50.87 52.38 
10 38.50 38.54 38.48 37.61 36.48 38.48 
11 22.89 21.15 22.98 23.01 24.32 22.98 
12 30.22 67.22 67.44 79.07 25.04 67.44 
13 41.66 46.86 46.01 47.05 26.89 46.01 
14 47.06 47.05 46.96 50.21 47.78 46.96 
15 33.36 33.40 33.34 33.35 31.34 33.34 
16 32.13 32.16 33.18 32.13 32.24 33.18 
17 52.41 52.41 52.38 52.39 50.38 52.38 
18 15.26 16.49 13.79 64.80 15.65 13.79 
19 17.03 17.07 17.01 17.06 20.44 17.01 
20 36.55 37.62 37.31 36.35 36.44 37.31 
21 21.11 18.10 21.11 21.13 21.88 21.11 
22 32.75 32.70 32.85 73.19 39.19 32.85 
23 27.57 27.55 27.50 125.25 24.29 27.50 
24 31.31 31.05 30.29 115.81 42.67 30.29 
25 29.06 30.26 30.20 30.23 25.13 30.20 
26 178.33 178.34 178.33 178.63 19.73 178.33 
27 23.30 23.01 23.34 23.34 19.41 23.34 
28 23.84 23.33 23.81 23.83 28.86 23.81 
29 28.26 28.87 63.91 28.85 16.64  27.25 
30 16.10 16.96 17.02 16.47 16.67  15.58 
1′ --- --- --- --- 106.32 101.53 
2′ --- --- --- --- 73.52 71.95 
3′ --- --- --- --- 68.49 67.17 
4′ --- --- --- --- 67.16 66.01 
5′ --- --- --- --- 61.23 76.53 
6′ --- --- --- --- -- 62.99 
1′′ --- --- --- --- 168.41 --- 
2′′ --- --- --- --- 127.40 --- 
3′′ --- --- --- --- 125.51 --- 
4′′ --- --- --- --- 130.06 --- 
5′′ --- --- --- --- 124.07 --- 
6′′ --- --- --- --- 125.84 --- 
 
RESULTS 
Elution of the column with petroleum ether gave arachidic acid (1). 
The compounds 2 and 3 were obtained in petroleum ether-
chloroform mixtures. Further elution of the column with chloroform 
and methanol mixtures afforded compounds from 4 to 8. All the 
phytoconstituents were obtained in crystalline forms. Diabetes was 
induced in rats by intraperitoneal injection of STZ solution. Aqueous 
solutions of the tested compounds were administered orally once a day.  
DISCUSSION 
Compounds 1 and 6 are the known compounds characterized as 
arachidic acid and β-sitosterol xylopyranoside [17].  
Compounds 2-8 responded positively to Liebermann-Burchard test 
and yielded effervescences with sodium bicarbonate solution 
indicating triterpenic acid nature of the molecules. Their IR spectra 
displayed characteristic absorption bands for hydroxyl functions 
(3410-3275 cm-1), carboxylic groups (1692-1688 cm-1) and 
unsaturation (1603-1650 cm-1). The molecular ion peaks were 
determined on the basis of mass and 13C NMR spectra and the 
position of vinylic bonds and functional groups were established on 
the basis of mass ion fragments. The 1H NMR spectra of the 
compounds displayed signals for vinylic protons from δ 6.79 to 5.03, 
oxygenated H-3α methine protons from δ 4.49-3.72 and methyl 
protons between δ 1.22–0.83, all attached to the saturated carbons. 
The 13C NMR spectra of the compounds exhibited signals for vinylic 
carbons from δ 143.92 to 115.81, carboxyl carbons near δ 178.33, C-
3 carbinol or oxygenated methine carbons between δ 83.61-77.85 
and methyl carbons in the upfield region from δ 28.87 to 13.79. The 
13C NMR spectrum of 7 displayed C-3 carbinol signal at δ 77.85, 
anomeric carbon at δ 106.32 (C-1′), aromatic signals at 168.41 (C-
1′′), 127.40 (C-2′′), 125.51 (C-3′′), 130.06 (C-4′′), 124.07 (C-5′′), 
12.84 (C-6′′), sugar carbons between δ 73.52-67.16 and aldehydic C-
7′′ carbon at δ 192.19. The 13C NMR spectrum of 8 also exhibited 
signals for anomeric carbon at δ 101.53 (C-1′) and other sugar 
carbons resonated between δ 76.53-62.99. The 1H and 13C NMR 
spectral data of the isolated compounds were compared with the 
lanosterol-type triterpenoids [18-20]. The 1H-1
Compound 2, 3, 4 and 8 were tested for the antidiabetic activity in 
STZ-induced diabetic models [21]. Table 1 shows the levels of blood 
glucose level in normal and experimental animals in each group. 
H COSY spectra of the 
triterpenoids showed correlations of the adjacent protons. The 
HMBC spectra of these compounds exhibited interactions of protons 
with the adjacent carbons. On the basis of spectral data analyses and 
chemical reactions, the structures of the isolated phytoconstituents 
were elucidated as lanost-7-en-3β-ol-26-oic acid (2), lanost-7-en-3β, 
12β-diol-26-oic acid (3), lanost-7-en-3β, 12β, 29-triol-26-oic acid 
(4), lanost-cis-1,7,23-trien-3β, 12β, 18, 22α-tetraol-26-oic acid (5), 
lanosteryl-3β-O-D-xylopyranosyl-2′-p-benzaldehyde (7) and lanost-
7-en-3β-ol-26-oic acid-3 β-D-glucopyranoside (8).  
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Fig. 1: Structural formulae of compounds 2-5, 7 and 8 
 
The isolated phytoconstituents have been found to show significant 
antidiabetic activity. In all the groups prior to STZ administration, 
the basal levels of blood glucose of the rats were not significantly 
different.  
However, after STZ administration, significant (P<0.001) elevation 
in blood glucose level was observed in diabetic control rats (group 
II) when compared with normal control rats (group I). Oral 
administration of the selected isolated compounds at a dose of 50 
mg/kg for one week significantly (P<0.001) reduced the blood 
glucose levels in diabetic rats as compared with diabetic control rats 
(table 2). This implies that the compounds can prevent or be helpful 
in controlling blood glucose level near to normal levels, a key for 
preventing or reversing diabetic complications. In conclusion, the 
present study demonstrates that the isolated compounds from the 
leaves of P. guajava at tested dose level exhibit potent antidiabetic 
potential in STZ-induced diabetic rats.  
Further studies are warranted in this area to outline precise 
mechanism behind the antihyperglycemic property of these 
compounds. 
 
Table 2: Effect of isolated compounds on blood glucose level in diabetic rats 
Groups Blood glucose (mg dl-1) 
0 d 3 d after STZ First week 
Normal control 90.34 ± 8.89 --- 87.66 ± 8.80 
Diabetic control 83.66 ± 11.62 311.50 ± 8.24 327.33 ± 6.41
Diabetic+compound 2(50 mg/kg) 
# 
100.67 ± 10.71 309.50 ± 8.57 172.17 ± 6.41** 
Diabetic+compound 3(50 mg/kg) 87 ± 11.78 310.16 ± 8.86 154.50 ± 6.06** 
Diabetic+compound 4(50 mg/kg) 84.50 ± 12.42 315.50 ± 6.38 142.50 ± 12.03** 
Diabetic+compound 8(50 mg/kg) 90.33 ± 12.88 325.66 ± 8.71 165.67 ± 8.73** 
The data are expressed in mean ± SD; n=6 in each group. #
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Six new lanosterol-type triterpenoids, arachidic acid, and β-sitosterol 
xylopyranoside were isolated from the leaves of Psidium guajava for 
the first time. The triterpenic constituents exhibited significant 
antidiabetic activity against streptozotocin-induced diabetic rats.  
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